PanLong Pharmaceutical Group's IPO

PanLong Pharmaceutical Group raised a round of funding on November 16, 2017. Investors include Public.

PanLong Pharmaceutical Group (盘龙药业) (SZSE: 002864) is engaged in the manufacture, research and development, and sales of Chinese medicines, focusing on the orthopedics and rheumatology fields.…

Articles about PanLong Pharmaceutical Group's IPO: